Medifast Lowers FY2019 EPS Guidance from $6.75-6.95 to $5.80-5.90 vs $6.83 Est; Raises FY2019 Sales Guidance from $730M-750M to $730M-750M vs $750.45M Est

Medifast (NYSE:MED) lowers FY2019 EPS guidance from $6.75-6.95 to $5.8-5.9 vs $6.83 analyst estimate. Raises FY2019 sales outlook from $730 million-750 million to $730 million-750 million vs $750.45 million estimate.

Benzinga · 11/07/2019 21:34

Medifast (NYSE:MED) lowers FY2019 EPS guidance from $6.75-6.95 to $5.8-5.9 vs $6.83 analyst estimate. Raises FY2019 sales outlook from $730 million-750 million to $730 million-750 million vs $750.45 million estimate.